Document Detail


Effects of prostacyclin on hearing recovery after repetitive noise and on histomorphology of the inner ear in the guinea pig.
MedLine Citation:
PMID:  7838480     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A probable relation between prostaglandin formation and the pathophysiology of hearing loss led to the application of the potent vasodilator prostacyclin in the treatment of inner ear disorders. Two drugs may be administered to humans: (1) unstable natural prostacyclin (epoprostenol) with a strong biological potency but with a high first-pass effect, or (2) a prostacyclin analogue (taprostene) with less biological activity, but a longer biological half-life and intravenous application. Therefore, the purpose of this study was to investigate potential differences of both drugs in their effect on the inner ear. The therapeutic potency of both drugs was evaluated in a recently developed animal model consisting in the recovery of hearing after a temporary threshold shift obtained by two noise exposures at 100 dB. In addition, the ultrastructure of the stria vascularis was examined by electron microscopy after the application of the drugs. After administering epoprostenol (12 ng/kg body weight/min) and taprostene (25 ng/kg body weight/min) histomorphological alterations in the stria vascularis did not differ from the controls. In the repetitive low-level noise model, neither drug showed a significant difference in its effect on the recovery of the hearing threshold. The results indicate that in the guinea pig epoprostenol has the same effect on the hearing threshold as the stable analogue taprostene, as shown by auditory brain stem response.
Authors:
O Michel; M Walger; A Schrott-Fischer
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  ORL; journal for oto-rhino-laryngology and its related specialties     Volume:  56     ISSN:  0301-1569     ISO Abbreviation:  ORL J. Otorhinolaryngol. Relat. Spec.     Publication Date:    1994 Nov-Dec
Date Detail:
Created Date:  1995-02-28     Completed Date:  1995-02-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0334721     Medline TA:  ORL J Otorhinolaryngol Relat Spec     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  305-9     Citation Subset:  IM    
Affiliation:
Department of Otorhinolaryngology, University of Cologne, FRG.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Ear, Inner / drug effects*,  pathology
Epoprostenol / analogs & derivatives*,  pharmacology*,  therapeutic use
Evoked Potentials, Auditory, Brain Stem
Female
Guinea Pigs
Hearing / drug effects*,  physiology
Hearing Loss, Noise-Induced / drug therapy*,  pathology,  physiopathology
Microscopy, Electron
Noise / adverse effects*
Prostaglandins, Synthetic / pharmacology*,  therapeutic use
Stria Vascularis / drug effects,  pathology
Time Factors
Chemical
Reg. No./Substance:
0/Prostaglandins, Synthetic; 35121-78-9/Epoprostenol; 87440-45-7/taprostene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Extensive idiopathic apical root resorption. A case report.
Next Document:  X-ray microanalysis and ion microscopy of guinea pig cochlea and kidney after cisplatin treatment.